Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome.

× No keyword cloud information.

8 in total

Review 1. Restless legs syndrome: a review of clinical and pathophysiologic features.

Authors: R P Allen; C J Earley
Journal: J Clin Neurophysiol Date: 2001-03 Impact factor: 2.177

2. Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report.

Authors: José Haba-Rubio; Luc Staner; Françoise Cornette; Erik Lainey; Rémy Luthringer; Jean Krieger; Jean P Macher
Journal: Neurophysiol Clin Date: 2003-09 Impact factor: 3.734

Review 3. Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors: Svenja Happe; Claudia Trenkwalder
Journal: CNS Drugs Date: 2004 Impact factor: 5.749

4. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.

Authors: I Reuter; C M Ellis; K Ray Chaudhuri
Journal: Acta Neurol Scand Date: 1999-09 Impact factor: 3.209

Review 5. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors: Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal: Sleep Med Date: 2003-03 Impact factor: 3.492

6. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.

Authors: Arthur S Walters; Cheryl LeBrocq; Anjana Dhar; Wayne Hening; Ray Rosen; Richard P Allen; Claudia Trenkwalder
Journal: Sleep Med Date: 2003-03 Impact factor: 3.492

7. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.

Authors: Svenja Happe; Cornelia Sauter; Gerhard Klösch; Bernd Saletu; Josef Zeitlhofer
Journal: Neuropsychobiology Date: 2003 Impact factor: 2.328

Review 8. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.

Authors: A S Walters
Journal: Mov Disord Date: 1995-09 Impact factor: 10.338

8 in total

4 in total

Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome.

Review 1. Restless legs syndrome: a review of clinical and pathophysiologic features.

2. Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report.

Review 3. Role of dopamine receptor agonists in the treatment of restless legs syndrome.

4. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.

Review 5. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

6. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.

7. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.

Review 8. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.

1. Continuous Subcutaneous Apomorphine Infusion Improves Severe Restless Legs Syndrome.

2. Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).

Review 3. Restless legs syndrome: pathophysiology, diagnosis and treatment.

Review 4. The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.